Deme Karikios

Clinical Associate Professor Deme Karikios is affiliated with the University of Sydney through the Sydney Medical School and Nepean Clinical School. As a Clinical Associate Professor in medical oncology, his work bridges clinical practice, health economics, and cancer treatment policy.

Research Interests focus on:

• Predictive biomarkers for chemotherapy response (e.g., Activin-A, GDF-11)
• Financial toxicity in cancer care
• Immunotherapy-related adverse events
• Lung cancer treatment modeling and screening economics
• Health equity in clinical trial access
• Medical oncology workforce sustainability

Publications highlight trends in:

• 2023–2025: Emphasis on risk-based lung cancer screening economics, biomarker validation, and systemic therapy patterns
• 2020–2022: Impact of the COVID-19 pandemic on cancer care, pembrolizumab in mesothelioma, and cost communication in clinical practice
• 2016–2019: Longitudinal analysis of anticancer drug costs, workforce dynamics, and clinical trial consent processes

Collaborations include multidisciplinary teams across Australian healthcare institutions, University of Sydney, and international oncology networks. No scientific awards are explicitly mentioned in the provided data.